US Patent

US9364564 — Pre-mixed, ready-to-use pharmaceutical compositions

Formulation · Assigned to EKR Therapeutics Inc · Expires 2027-12-26 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pre-mixed, ready-to-use pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt for treating cardiovascular and cerebrovascular conditions.

USPTO Abstract

Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.

Drugs covered by this patent

nicardipine-hydrochloride (NICARDIPINE HYDROCHLORIDE)

Patent Metadata

Patent number: US9364564
Jurisdiction: US
Classification: Formulation
Expires: 2027-12-26
Drug substance claim: No
Drug product claim: Yes
Assignee: EKR Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.